임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 3상모집 예정· Schizophrenia; Psychosis조현병 성인 환자에서 24주 및 52주 치료 후 크산올리딘/트로스피움(XT)의 인지장애 개선 효능 평가 연구
A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With Schizophrenia
협력: BMS
- 3상모집 예정· Pulmonary Fibrosis폐섬유증 환자에서 애드밀파란트의 안전성 및 내약성을 평가하는 장기 추적 연구
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
리드: BMS
- 3상모집 예정· Irritability Associated With Autism Spectrum DisorderA Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
리드: BMS
- 3상모집 예정· Irritability Associated With Autism Spectrum DisorderA Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism
리드: BMS
- 3상모집 중· Non-small Cell Lung Cancer (NSCLC)A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Non-Small Cell Lung Cancer (NSCLC)A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
리드: BMS · 협력: 바이오엔테크
- 3상모집 중· Breast NeoplasmsROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
리드: 바이오엔테크 · 협력: BMS
- 3상모집 중· Plaque PsoriasisLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
리드: BMS
- 3상모집 중· Bipolar Disorder Type I With ManiaA Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
리드: BMS
- 3상모집 중· Alzheimer's DiseaseA Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
리드: BMS
- 3상모집 중· Bipolar Disorder Type I With Mania or Mania With Mixed FeaturesA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
리드: BMS
- 3상모집 중· Bipolar-I Disorder With Mania or Mania With Mixed FeaturesA Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
리드: BMS
- 3상모집 중· Multiple Sclerosis, Relapsing-RemittingStudy to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
리드: BMS
- 3상모집 중· Juvenile Psoriatic ArthritisA Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis
리드: BMS
- 3상모집 중· Relapsed or Refractory Multiple Myeloma (RRMM)A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)
리드: BMS
- 3상모집 중· Extensive-Stage Small Cell Lung CancerA Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
리드: BMS
- 3상모집 중· Extensive-stage Small-cell Lung CancerSafety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
리드: 바이오엔테크 · 협력: BMS
- 3상모집 중· Alzheimer DiseaseA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
협력: BMS
- 3상모집 중단 (진행 중)· Cardiomyopathy, HypertrophicA Study to Evaluate Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
리드: BMS
- 3상모집 중· Multiple MyelomaIberdomide vs. Iberdomide Plus Isatuximab Maintenance Therapy Post ASCT in Newly Diagnosed Multiple Myeloma
협력: BMS, 사노피
- 3상모집 중단 (진행 중)· Carcinoma, Non-Small-Cell LungA Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
리드: BMS
- 3상모집 중단 (진행 중)· Progressive Pulmonary FibrosisA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
리드: BMS
- 3상모집 중단 (진행 중)· Myelodysplastic SyndromesELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions
리드: BMS
- 3상모집 중단 (진행 중)· Multiple MyelomaA Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation
협력: BMS
- 3상모집 중단 (진행 중)· Myelodysplastic SyndromesA Study to Assess Luspatercept in Lower-risk Myelodysplastic Syndrome Participants
리드: BMS
- 3상모집 중단 (진행 중)· Idiopathic Pulmonary FibrosisA Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis
리드: BMS
- 3상모집 중단 (진행 중)· Sjögren's SyndromeA Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
리드: BMS
- 3상모집 중· Psychosis Associated With Alzheimer's DiseaseA Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
협력: BMS
- 3상모집 중· Psychosis Associated With Alzheimer's DiseaseOpen-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
협력: BMS
- 3상모집 중단 (진행 중)· Atrial FibrillationA Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Ischemic Stroke; Ischemic Attack, TransientA Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE
리드: 얀센(J&J) · 협력: BMS
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)
리드: BMS
- 3상모집 중단 (진행 중)· Systemic Lupus ErythematosusA Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus
리드: BMS
- 3상모집 중단 (진행 중)· Relapsed or Refractory Multiple MyelomaA Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)
리드: BMS
- 3상모집 중단 (진행 중)· IgG4 Related DiseaseA Phase 3 Study of Obexelimab in Patients With IgG4-Related Disease
협력: BMS
- 3상모집 중· Newly Diagnosed Multiple MyelomaNDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
협력: BMS, 사노피
- 3상모집 중· Psychosis Associated With Alzheimer's DiseaseA Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)
협력: BMS
- 3상모집 중단 (진행 중)· Unresectable or Metastatic MelanomaStudy Comparing Investigational Drug HBI-8000 + Nivolumab vs. Placebo + Nivolumab in Patients With Advanced Melanoma
협력: BMS
- 3상모집 중· Renal Allograft RecipientsA Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications
리드: BMS
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.